A 2014 update on the management of patients with systemic lupus erythematosus

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 2, 2014, Pages e1-e2

  Merrill, Joan T ^a,b   Buyon, Jill P ^c   Utset, Tammy ^d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELIMUMAB; BIOLOGICAL FACTOR;

COMORBIDITY; DIAGNOSTIC PROCEDURE; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INFECTION RISK; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXICITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTOR;

BIOLOGICAL FACTORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 84927517277     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.09.013     Document Type: Note

References (0)